No Detail Found!

Potentially Resectable mCRC-treated with Cetuximab Combined with Chemotherapy

Author(s)
Liang Hong Department of Oncology, The First People's Hospital of Xiaoshan District,Hangzhou,China
Xiaocheng Xu Department of Oncology, The First People's Hospital of Xiaoshan District,Hangzhou,China
Abstract
Surgical resection of a potentially resectable metastatic colorectal cancer (mCRC) may lead to additional clinical bene ts for the patients. In some cases, patients with initially unresectable lesions can be converted to resectable ones after induction of chemotherapy; and these patients are primarily treated with uorouracil-based systemic chemotherapy preoperatively. However, the optimal protocol for neoadjuvant therapy has not been determined yet, and it remains a source of controversy about whether systemic chemotherapy combined with cetuximab can increase the surgical resection rate and obtain more clinical bene ts. Metastatic CRC patients that received chemotherapy combined with cetuximab were compared with those undergoing chemotherapy alone. The hazard ratio (HR) and odds ratio (OR) were used as the e cacy indicators. The 95% con dence interval (95% CI) was used as interval estimation method. Seven studies including 1,895 patients were selected. Compared with patients undergoing chemotherapy, the patients receiving systemic chemotherapy combined with cetuximab of the R0 resection was not improved (OR=1.25; 95% CI, 0.76-2.06; p=0.08); The progression-free survival (PFS) of the patients received chemotherapy combined with cetuximab was slightly longer than those received chemotherapy alone (HR=0.88; 95% CI, 0.77-1; p=0.005); and the overall survival (OS) of patients undergoing systemic chemotherapy combined with cetuximab was not prolonged relative to that in patients receiving chemotherapy alone (HR=0.98; 95% CI, 0.86-1.11; p=0.04). Compared with patients receiving chemotherapy alone, the surgical resection rate and PFS are not increased in patients undergoing chemotherapy combined with cetuximab, but the OS is slightly prolonged.
Publication Details
Page(s) 1206-1212
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 30, Issue: 11, Year: 2020

Request the full text from PASTIC

Keywords
Surgery, colorectal cancer, chemotherapy, Metastatic tumor, Cetuximab
0

Citations

0

Downloads

83

Views